In the latest trading session, 0.56 million Genenta Science SpA ADR (NASDAQ:GNTA) shares changed hands as the company’s beta touched 0.68. With the company’s most recent per share price at $3.66 changed hands at -$0.14 or -3.68% at last look, the market valuation stands at $66.94M. GNTA’s current price is a discount, trading about -98.91% off its 52-week high of $7.28. The share price had its 52-week low at $2.20, which suggests the last value was 39.89% up since then. When we look at Genenta Science SpA ADR’s average trading volume, we note the 10-day average is 6880.0 shares, with the 3-month average coming to 11.14K.
Analysts gave the Genenta Science SpA ADR (GNTA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended GNTA as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Genenta Science SpA ADR (NASDAQ:GNTA) trade information
Instantly GNTA was in red as seen in intraday trades today. With action -7.11%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -15.86%, with the 5-day performance at -7.11% in the red. However, in the 30-day time frame, Genenta Science SpA ADR (NASDAQ:GNTA) is -10.07% down. Looking at the short shares, we see there were 1535.0 shares sold at short interest cover period of 0.26 days.
Genenta Science SpA ADR (NASDAQ:GNTA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 39.26% of Genenta Science SpA ADR shares while 8.23% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 13.55%. There are 8.23% institutions holding the Genenta Science SpA ADR stock share, with CARTESIAN GROWTH CORP the top institutional holder. As of 2024-06-30, the company held 1.0995% of the shares, roughly 0.2 million GNTA shares worth $0.62 million. ALGEBRIS (UK) LTD holds the second largest percentage of outstanding shares, with 0.247% or 45000.0 shares worth $0.13 million as of 2024-06-30.
